Slideshow

Toward Biomarker-Guided Treatment in Psychosis

Author(s):

Brian Miller, MD, PhD, MPH

Is oxidative stress a therapeutic target in schizophrenia?

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
nicotine use
brain schizophrenia
schizophrenia
schizophrenia
exciting, brain
Related Content
antipsychotics
December 19th 2024

Antipsychotic Prescriptions and Rehospitalizations in a Forensic Psychiatry Sample

Leah Kuntz
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
schizophrenia
December 11th 2024

Combating Negative Symptoms in Schizophrenia: Updated Treatment Approaches

Michel Sabé, MD
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD
Synaptic Dysfunction in Psychosis Explored at ACNP Meeting
December 10th 2024

Synaptic Dysfunction in Psychosis Explored at ACNP Meeting

Heidi Anne Duerr, MPH M Belén Blasco, MD Romina Mizrahi, MD, PhD
catatonia
December 9th 2024

From Stupor to Success: Managing Catatonia in Rural South Africa, A Case Report

Grace Lehnerdt, MD
© 2024 MJH Life Sciences

All rights reserved.